Both in Pharmaceuticals
Tilray Brands vs Crescent Biopharma
Over the past year TLRY returned −78.6% and CBIO returned +20.1%; their daily moves had a correlation of 0.14.
TLRY −78.6% CBIO +20.1%Growth of $1, one year, split-adjusted
| Metric | TLRY | CBIO |
|---|---|---|
| Price | $3.95 | $14.76 |
| Market cap | $583.7M | $548.3M |
| Today | −1.74% | +1.58% |
| 1 month | −13.9% | −16.8% |
| 6 months | −34.1% | −11.2% |
| Year to date | −56.3% | +24.5% |
| 1 year | −65.7% | +18.7% |
| Revenue growth (YoY) | +25.5% | — |
| Gross margin | 32.1% | — |
| Net margin | −17.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.6× | 46.1× |
| Net cash | $83.9M | $171.6M |
| Dividend yield | — | — |
| Volatility (60d) | 46.2% | 77.0% |
| Short % of float | 14.4% | 16.3% |
| Next earnings | Oct 8, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).